Recombinant Human CMBL Protein，His

CMBL, or Carboxymethylated Bovine Lactoferrin, is a recombinant protein derived from bovine lactoferrin, which is a multifunctional glycoprotein found in milk and other bodily fluids. It possesses various biological activities, including antimicrobial, antioxidant, and immunomodulatory properties, making it a subject of interest in biomedical research. The process of recombinant protein technology allows for the production of CMBL in a controlled environment, ensuring consistent quality and functionality. Researchers have been investigating the potential applications of CMBL in various fields, including nutrition, pharmaceuticals, and therapeutics, due to its ability to enhance iron absorption, support gut health, and modulate immune responses. Studies have also explored its role in preventing infections and inflammatory diseases, as well as its potential as a co-adjuvant in vaccine formulations. Given the increasing demand for functional foods and biopharmaceuticals, the investigation of CMBL offers promising avenues for innovation in health and disease management. Understanding its mechanisms of action and optimizing its production could lead to new strategies for improving health outcomes, particularly in populations with specific nutritional needs or compromised immune systems. The ongoing research into CMBL aims to elucidate its biological interactions and enhance its applications in clinical settings, contributing to the advancement of functional protein-based therapies.